Media Hub

Jul 2017

Kidney cancer drug given approval for NHS use for England

The drug, cabozantinib, can potentially turn off tumours and prolong the lives of patients with advanced kidney cancer. Treatment options for kidney cancer are currently limited and according to the charity Kidney Research UK, the new drug would offer patients “more hope and more time with their loved ones”. The drug works by targeting molecules…

Read More

Oct 2016

Cancer immunotherapy drug potential ‘game changer’

The European Cancer Congress has presented promising results in a study of 350 head and neck cancer patients. In the study, the number of patients surviving for longer whilst taking the drug, nivolumab, exceeded those being treated with chemotherapy. In the trial published in the New England Journal of Medicine, 36% of the patients trialled…

Read More